(Date:12/6/2009)... -- Sickle cell disease, a condition characterized by ... of the most common genetic blood disorders affecting ... than 70,000 Americans.(1) Research presented today at the ... Hematology highlights intriguing studies on the acute danger ... this blood disorder, evaluations of both new and ...
(Date:12/6/2009)... A new study provides welcome news for patients with ... , The condition is estimated to impact 62,000 ... an abnormal clot forms in a vein and restricts ... some cases, the clot may detach from its point ... lungs, causing a potentially fatal condition known as a ...
(Date:12/6/2009)... with the Greater VA Healthcare System in West Los Angeles, will ... to soar to more than 5,000 veterans, active military personnel and ... ... 2009 -- Volunteer organizations and members of the community, in cooperation ... once again create a holiday party. This year,s attendance is expected ...
(Date:12/5/2009)... has shown in a phase 1/2 clinical trial ... treatment of patients newly diagnosed with multiple myeloma, a ... researchers from Dana-Farber Cancer Institute. , Partial responses or ... treated with the drug combination in the multi-center study, ... rate" in the phase 2 population, reports Paul G. ...
(Date:12/5/2009)... 5 ,, What: Cuts for a ... in the fight against cancer and other terminal illnesses affecting ... donated to St. Jude Children,s Research Hospital. Guests will enjoy ... delectable and savory Vietnamese restaurant in Falls Church for all ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2(Date:12/4/2009)... 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... and webcast. Principal investigators will discuss the data ... as featured at the 51st American Society of Hematology ... 9:00 a.m. CT/10:00 a.m. ET on Monday, December 7, ...
(Date:12/4/2009)... World recently highlighted a new report published ... ( PhRMA ) that identifies 97 new drugs and vaccines ... report found that the 97 products in development include ... human clinical trials or awaiting approval by the U.S. Food ...
(Date:12/4/2009)... Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: ... testing of a novel integrated light source architecture for ... design raises the bar on imaging speed and overcomes ... light sources. This approach to optical engines builds ...
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 1President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 2President Obamas Health Care Plan 3A Too Big Too Expensive Too Rushed 52500 3Digirad Corporation Reports Second Quarter 2009 Financial Results 52497 1Digirad Corporation Reports Second Quarter 2009 Financial Results 52497 2Digirad Corporation Reports Second Quarter 2009 Financial Results 52497 3Digirad Corporation Reports Second Quarter 2009 Financial Results 52497 4Digirad Corporation Reports Second Quarter 2009 Financial Results 52497 5Digirad Corporation Reports Second Quarter 2009 Financial Results 52497 6Digirad Corporation Reports Second Quarter 2009 Financial Results 52497 7St John 26apos 3Bs Hospital Acquires Latest Technology in Robotic Assisted Surgery 52495 1St John 26apos 3Bs Hospital Acquires Latest Technology in Robotic Assisted Surgery 52495 2St John 26apos 3Bs Hospital Acquires Latest Technology in Robotic Assisted Surgery 52495 3... May 23, 2007 (BUSINESS WIRE) -- MGI ... oncology and,acute care, today announced the presentation ... trial of Aquavan(R) (fospropofol,disodium) Injection in patients ... as well as safety data, were,presented at ...
... Late Thrombosis is Minimized with Genous Stent, BARCELONA, ... of,OrbusNeich's Genous(TM) Bio-engineered R stent compares favorably,to that ... thrombosis,is minimized with the Genous stent, according to ... Robbert de,Winter, M.D., Ph.D., at EuroPCR 2007 in ...
Other Medicine Technology:Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 2Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 3Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 4Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 5Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares,Favorably to Drug-Eluting Stents 2Efficacy of OrbusNeich's Genous Bio-Engineered R Stent Compares,Favorably to Drug-Eluting Stents 3... Test is a rapid in vitro qualitative test ... Virus Type 1 in human whole blood, serum ... by trained personnel in medical facilities, clinical laboratories, ... screening assay capable of providing test results in ...
... In the fast-paced world of echo ... make a real difference in your ability ... developed Xcelera Echo Lab Management, a unique ... providing the tools your department needs to ...
... AutoSet Spirit is the premium APAP device ... S7. The AutoSet algorithm responds to the ... The flow generator stores and reports comprehensive ... The AutoSet devices combine integrated humidification and ...
... The GoodKnight® 420 CPAP System includes the ... auto-CPAP therapy can enjoy the advantages of ... airway pressure devices. The GoodKnight 420E model ... data and includes other features of the ...
Medicine Products: